PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Bharat Biotech Initiates P-III Study for Covaxin Against COVID-19

Bharat Biotech Initiates P-III Study for Covaxin Against COVID-19

November 17, 2020

Moderna's mRNA-1273 Demonstrates 94.5% Efficacy in Preventing Symptomatic COVID-19

Moderna's mRNA-1273 Demonstrates 94.5% Efficacy in Preventing Symptomatic COVID-19

November 17, 2020

Zymeworks and ALX Oncology Collaborate to Evaluate Zanidatamab + ALX148 for Advanced HER2‑Expressing Breast Cancer

Zymeworks and ALX Oncology Collaborate to Evaluate Zanidatamab + ALX148 for Advanced HER2‑Expressing Breast Cancer

November 17, 2020

Roche Signs a License Agreement with Lead Pharma to Develop Oral Therapies for Immune-Mediated Diseases

Roche Signs a License Agreement with Lead Pharma to Develop Oral Therapies for Immune-Mediated Diseases

November 17, 2020

Johnson & Johnson Initiates Second Global P-III Study of its COVID-19 Vaccine

Johnson & Johnson Initiates Second Global P-III Study of its COVID-19 Vaccine

November 17, 2020

QBiotics' Stelfonta (tigilanol tiglate) Receives the US FDA's Approval as the First Treatment for Non-Metastatic MCT in Dogs

QBiotics' Stelfonta (tigilanol tiglate) Receives the US FDA's Approval as the First Treatment for Non-Metastatic MCT in Dogs

November 17, 2020

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us